A Comparison of the Direct Costs and Cost Effectiveness of Serotonin Reuptake Inhibitors and Associated Adverse Drug Reactions

Author： Sullivan Patrick W.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.18, Iss.13, 2004-01, pp. : 911-932

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Economic Impact of Introducing Serotonin-Noradrenaline Reuptake Inhibitors into the Brazilian National Drug Formulary: Cost-Effectiveness and Budget-Impact Analyses

By Machado Márcio   Iskedjian Michael  

PharmacoEconomics, Vol. 25, Iss. 11, 2007-01 ,pp. : 979-990

Adis International

Access to resources Recommend Favorite

Use of Bayesian Net Benefit Regression Model to Examine the Impact of Generic Drug Entry on the Cost Effectiveness of Selective Serotonin Reuptake Inhibitors in Elderly Depressed Patients

By Ya-Chen Tina Shih   Bekele Nebiyou B.   Xu Ying  

PharmacoEconomics, Vol. 25, Iss. 10, 2007-01 ,pp. : 843-862

Adis International

Access to resources Recommend Favorite

Adverse Reactions of Selective Serotonin Reuptake Inhibitors: Reports from a Spontaneous Reporting System

By Spigset O.  

Drug Safety, Vol. 20, Iss. 3, 1999-03 ,pp. : 277-287

Adis International

Access to resources Recommend Favorite

The cost of adverse drug reactions

By Gautier Sophie   Bachelet Hélène   Bordet Régis   Caron Jacques  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 3, 2003-03 ,pp. : 319-326

Informa Healthcare

Access to resources Recommend Favorite

Analysis of the direct cost of adverse drug reactions in hospitalised patients

By Bordet R.   Gautier S.   Le Louet H.   Dupuis B.   Caron J.  

European Journal of Clinical Pharmacology, Vol. 56, Iss. 12, 2001-03 ,pp. : 935-941

Springer Publishing Company

Access to resources Recommend Favorite